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Edited by Lukas HuberAbstract Taurine has been reported to inﬂuence bone metabo-
lism, and its speciﬁc transport system, the taurine transporter,
is expressed in osteoblasts. The mean [Mg2+]i was
0.51 ± 0.01 mM in normal culture media. Taurine caused an in-
crease in [Mg2+]i by 0.72 ± 0.04 mM in human osteoblast
(HOB) cells. This increment in [Mg2+]i was inhibited signiﬁ-
cantly by PD98059, nifedipine, lidocaine, and imipramine. Tau-
rine was also shown to stimulate the activation of ERK 1/2. This
taurine-stimulated ERK 1/2 activation was inhibited by
PD98059. In the present study, taurine was shown to increase
cell proliferation and generate an increase in [Mg2+]i accompa-
nied by ERK 1/2 activation in HOB cells.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
Keywords: Taurine; Intracellular magnesium; ERK 1/2;
Human osteoblast cell; PD980591. Introduction
Taurine, 2-aminoethanesulfonic acid, is the principal free
b-amino acid in mammals, and is also detected in high concen-
trations in the brain, heart, eye, muscle, and liver. It can be
synthesized from cysteic acid or hypotaurine, which is derived
from methionine and cysteine within the body [1]. A variety of
physiological roles have been suggested for taurine, including
calcium modulation, membrane stabilization, the intracellular
regulation of osmosis, and the regulation of protein phosphor-
ylation [2–5]. Thus, changes in the net cellular taurine content
may exert a dramatic impact on cell function. Taurine has been
shown to inﬂuence bone metabolism, and its speciﬁc transport
system, the taurine transporter, is expressed in osteoblastsAbbreviations: MAPK, mitogen-activated protein kinase; ERK 1/2,
extracellular signal-regulated kinase 1/2; HOB, human osteoblast;
LDH, lactate dehydrogenase; [Mg2+]i, intracellular Mg2+ concentra-
tion
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doi:10.1016/j.febslet.2007.11.035[6,7]. Furthermore, taurine promotes the expression of connec-
tive tissue growth factor (CTGF) in osteoblasts via the ERK
signal pathway [8]. Moreover, taurine has been determined
to inhibit experimental bone resorption and the formation
and survival of osteoclasts [9].
In association with bone metabolism, the results of a number
of studies have shown that divalent cations, including Mg2+,
perform a pivotal role in bone remodeling and skeletal devel-
opment [10,11]. Mg2+ exists in macronutrient quantities in
bone (0.5–1% bone ash), and dietary Mg2+ deﬁciencies have
been implicated as a risk factor for osteoporosis. The eﬀect
of selective dietary Mg2+ depletion has been studied exten-
sively in the rat. Impaired bone growth, reduced bone forma-
tion, increased bone resorption, osteoporosis, and increased
skeletal fragility have all been observed [12–16]. Recently,
Kim et al. [17] reported that the augmentation of intracellular
magnesium ([Mg2+]i) in H9C2 cells is related to the activation
of the ERK signal pathway.
The present study attempted to determine the eﬀects of tau-
rine treatment on cell proliferation, intracellular Mg2+ regula-
tion, and the activation of mitogen-activated protein kinase
(MAPK) in human osteoblast (HOB) cells.2. Materials and methods
2.1. Materials
Dulbecco’s modiﬁed eagle’s medium nutrient mixture F-12 HAM
(DMEM-F12 HAM) media were purchased from Sigma (St. Louis,
MO). Fetal calf serum was acquired from Gibco (Grand Island,
NY). Mag-fura-2AM was obtained from Molecular Probes (Eugene,
OR). The MAPK inhibitor (PD98059), taurine, calcium channel block-
er (nifedipine), sodium channel blocker (lidocaine, imipramine) and
other materials were purchased from Sigma.
2.2. Cell culture
HOB cells were purchased from ATCC (No.CRL-11372). The HOB
cell line was grown on 50 mL tissue culture ﬂasks in DMEM-F12
HAM media: this was supplemented with 10% fetal calf serum,
5 mM L-glutamine, 50 U/mL of penicillin, and 50 lg/mL of streptomy-
cin in a humidiﬁed 5% CO2–95% air environment at 37 C.
For the performance of the ﬂuorescent studies, conﬂuent cells were
washed three times in phosphate-buﬀered saline (PBS) containing
5 mM ethylene glycol-bis (b-aminoenylyl ether) N,N,N 0,N 0-tetraacetic
acid (EGTA); they were then trypsinized and seeded onto glass cover-
slips. Aliquots of the harvested cells were permitted to settle on sterileblished by Elsevier B.V. All rights reserved.
5930 S.-H. Jeon et al. / FEBS Letters 581 (2007) 5929–5934glass coverslips in 100-mm Corning tissue culture dishes, and the cells
were grown to subconﬂuence over 1–2 days in supplemented media, as
was described above.2.3. Lactate dehydrogensae (LDH) measurements
HOB cells were grown on 6-well plates (8 · 104/well), and cultured
for 48 h in DMEM-F12 HAM media containing 10% fetal calf serum.
The HOB cells were either left untreated, or treated with 10 mM tau-
rine, or 20 mM taurine, for 48 h. Culture media were collected and uti-
lized to measure LDH activity via a chemical colorimetric method.
LDH activity was determined by measuring the level of pyruvic acid
with a spectrophotometer (SpectraMax ﬂuorometer with SoftMax
Programme Molecular Probes, USA), and the absorbance was deter-
mined at a wavelength of 490 nm.2.4. The MTT test
The centrifuged deposits of control or treated cells were washed
twice with PBS and were then treated with approximately 50 lL of
the MTT solution (0.5 mg/mL PBS); the tubes, after mixing of the con-
tents by side-tapping, were incubated at 37 C for 3 h. The tubes con-
taining MTT-cell mixtures were centrifuged (400 · g for 10 min) to
deposit the cells, the supernatant MTT solution was pipetted out
and then acid–isopropanol (95 mL isopropanol with 5 mL 3 N HCl)
was added to the colored cell deposit. After stirring of the acid–alco-
hol-treated deposit with a glass rod, the mixture was allowed to react
for 5 min, followed by centrifugation at 400 · g for 10 min. One hun-
dred microliter of the purple-blue colored supernatant that contained
the solubilized formazan in each sample was added to a well in a 96-
well plate for spectrophotometry at 570 nm in an ELISA reader.
Acid–isopropanol was used as a blank in the readings.2.5. Total magnesium measurements
After 48 h, conﬂuent cells were washed three times in PBS. After
washing, the cells were scraped with a cell scraper. The harvested cells
were homogenized immediately and the extract was transferred to a
1.5-mL microfuge tube, which was placed on ice. The sample was then
sonicated for ﬁve pulses at a 40% duty cycle using a Sonics & Materials
Ultrasonic Processor (USA), then microcentrifuged for 10 min at
10000 rpm. The supernatant was collected and used to measure total
magnesium with an atomic absorption spectrophotometer (Analab
9200, Seoul, Korea) at a wavelength of 285.2 nM.2.6. Cytoplasmic Mg2+ measurements
The coverslips were mounted in a perfusion chamber, and the intra-
cellular concentration of free Mg2+ ([Mg2+]i) was determined using the
Mg2+-sensitive ﬂuorescent dye, Mag-fura-2AM (Molecular Probes).
The cell-permeant aceoxymethyl ester (AM) from the dye was dis-
solved in dimethyl sulfoxide (DMSO) to make a stock concentration
of 5 mM, and this was diluted to 2.5 lM with mag-fura-2AM in media
for 30 min at 37 C. The cells were then washed three times in buﬀered
salt solution containing (in mM): 145 NaCl, 4.0 KCl, 0.8 K2HPO4, 0.2
KH2PO4, 1.0 CaCl2, 5.0 glucose, and 20 N-2-hydroxyethylpiperazine-
N 0-2-ethanesulfonic acid (HEPES)/Tris (hydroxymethyl) aminometh-
ane (Tris) at a pH of 7.4. The HOB cells were incubated for an addi-
tional 30 min to allow for complete deesteriﬁcation, after which the
cells were washed once in this buﬀer solution prior to measuring the
ﬂuorescence.
Epiﬂuorescence microscopy was employed to monitor the changes in
Mag-fura-2AM within the single HOB cells. The chamber (0.5 mL)
was mounted on an inverted Nikon Diaphot-TMD microscope
equipped with a FluorX100 objective, and the ﬂuorescence was moni-
tored within a single cell under oil immersion over the course of the
study. The ﬂuorescence was recorded at 1-s intervals with a dual-exci-
tation wavelength spectrophotometer (Delta-scan, Photon Technolo-
gies, Princeton, NJ) with the excitation wavelengths for mag-fura-2
at 340 and 380 nm (the chopper speed was set at 100 Hz), and an emis-
sion wavelength of 495 nm. All of the experiments were conducted at
23 C with continuous exchange of the bathing solution (1 mL/min).
Media changes were conducted without interrupting the recording.
The [Mg2+]i was calculated from the ratio of the ﬂuorescence at the
two excitation wavelengths as described previously, using a dissocia-
tion constant (Kd) of 1.4 mM, for the Mag-fura-2/Mg
2+ complex.The Rmax for mag-fura-2 was determined via the addition of 50 mM
MgCl2 in the absence of Ca
2+, and the Rmin was obtained via the re-
moval of Mg2+ and the addition of 100 mM EDTA, at a pH of 7.2.
2.7. Western blot analysis of the MAPK (ERK 1/2)
After incubation, the medium was aspirated and the cells were
washed three times in 100 ll of ice-cold PBS SDS sample buﬀer
(2.5 mM Tris–HCl, 2% SDS, 10% glycerol, 50 mM DTT, and 0.1%
bromophenol blue, pH 6.8). The cells were homogenized immediately
and the extract was transferred to a 1.5-mL microfuge tube, which was
placed on ice. The sample was then sonicated for ﬁve pulses at 40%
duty cycle using a Sonics & Materials Ultrasonic Processor (USA),
then microcentrifuged for 30 min at 14000 rpm. Thirty microliters of
the supernatant was loaded onto 7.5% SDS–PAGE gel. After conduct-
ing electrophoresis, the protein was electrotransferred to a Hybond-
ECL nitrocellulose membrane. The membrane was blocked with
Tris-buﬀered saline (20 mM Tris and 140 mM NaCl, pH7.6) contain-
ing 0.1% Tween20 (TBST) and 5% milk for 2 h at room temperature.
The membrane was then incubated overnight with monoclonal phos-
phospeciﬁc p44/42 MAPK antibody, which was the primary antibody,
at a 1:1000 dilution in TBST with 5% milk at 4 C. The blot was then
washed three times for 10 min each in TBST (three times for 5 min
each) and the bands were detected using ECL with exposure to X-
OMAT AR ﬁlm. The blots were quantiﬁed via laser scanning densi-
tometry (Bio-Rad, USA).
2.8. Statistical analysis
The results were expressed as the means ± standard error of the
mean (S.E.M.). The data were analyzed via the Student’s t test and re-
peated-measures of analyses of variance (ANOVA) followed by the
Bonferroni test. A probability of less than 0.05 was considered to be
statistically signiﬁcant.3. Result
3.1. Eﬀect of taurine on proliferation and lactate dehydrogenase
(LDH) of HOB cells
In the control HOB cell culture, cellular proliferation grad-
ually increased until day 3. Microscopic observations indicated
that the cell growth pattern of taurine treatment was far higher
than that of the controls (Fig. 1A). It was proofed in the
MTT test (Fig. 1B). In order to determine whether taurine ex-
erts any cytotoxic eﬀects on HOB cells, LDH assays were
conducted by measuring the level of pyruvic acid with a
spectrophotometer. As is shown in panel C of Fig. 1, LDH
activities were reduced by 5 ± 0.3% and 10 ± 0.2% as the
result of treatment with 10 and 20 mM taurine in these cells,
respectively.
3.2. Eﬀect of taurine on total magnesium concentration and
[Mg2+]i in HOB cells
Taurine (10 and 20 mM) elicited a transient increase in total
magnesium in HOB cells. In the HOB cells, the mean total
magnesium content was determined to be 116 ± 0.30 lM/mg
protein (n = 10). As is shown in Fig. 2A, exposure to 10 mM
taurine (128 ± 0.15 lM/mg protein) and 20 mM taurine
(141 ± 0.56 lM/mg protein) generated a signiﬁcant increase
in total magnesium contents.
In the HOB cells, the mean [Mg2+]i at the extracellular Mg2+
concentration ([Mg2+]o, 1 mM) buﬀer was determined to be
0.51 ± 0.01 mM (n = 26). Taurine generated a dose-dependent
increase in [Mg2+]i. Fig. 2B shows typical changes in the levels
of [Mg2+]i following exposure to taurine (10 and 20 mM). The
value of [Mg2+]i (0.54 ± 0.02 mM) after exposure to 10 mM
taurine was slightly increased from the control (0.51 ±
Fig. 2. Eﬀects of taurine (10 and 20 mM) on the total and intracellular
magnesium concentrations in HOB cells. The HOB cells were either
left untreated (control), or treated with taurine (10 and 20 mM) for
24 h. Total magnesium was measured via atomic absorption spectro-
photometry (A); typical recording (B) and data summary (C) of the
intracellular free magnesium concentration ([Mg2+]i) induced by 10
and 20 mM taurine in HOB cells. The data are reported as the
means ± S.E. of eight diﬀerent preparations. *P < 0.05 vs. control.
**P < 0.01 vs. control.
Fig. 1. Eﬀects of taurine (10 and 20 mM) on cell proliferation and
lactate dehydrogenase activity in HOB cells. HOB cells plated in six
wells were treated for 48 h with the indicated doses of taurine. Cell
morphology was assessed via microscopy (·200, A). Cell viability was
determined in accordance with lactate dehydogenase activity and MTT
test. The viability of control cells was set at 100%, and viability relative
to the control was expressed. The experiments were conducted at least
in triplicate (B,C). *P < 0.05 vs. control.
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in [Mg2+]i (0.72 ± 0.04 mM) in the HOB cells. The increase in
[Mg2+]i induced by 20 mM taurine was inhibited signiﬁcantly
by 10 lM PD98059 (0.51 ± 0.02 mM) as a speciﬁc ERK 1/2
antagonist, 10 lM nifedipine (0.53 ± 0.01 mM) as a calcium
channel blocking agent, and 10 lM lidocaine (0.53 ±
0.02 mM) and 10 lM imipramine (0.50 ± 0.02 mM) as fast so-
dium channel inactivators (Fig. 3B). The increment of [Mg2+]i
induced by 20 mM taurine remained unaltered in the presenceof extracellular 1 mM Mg2+ or in the absence of extracellular
magnesium (Fig. 3A).
3.3. Eﬀects of taurine on p38 MAP kinase and ERK 1/2 in
cultured HOB cells
The phosphorylation levels of ERK1/2 and p38 MAPK were
determined by conducting Western blotting after the cells were
Fig. 3. The mechnisms of taurine on increments of intracellular
magnesium concentration in HOB cells. The change in [Mg2+]i (n = 5)
induced by 20 mM taurine in the [Mg2+]o-free buﬀer was similar to the
1 mM [Mg2+]o buﬀer (A). *P < 0.05 vs. control. Data summary (B) of
the intracellular free magnesium concentration ([Mg2+]i) induced by
20 mM taurine in HOB cell. PD, 10 lM PD98059; nife, 10 lM
nifedipine; lido, 10 lM lidocaine; imi, 10 lM imipramine. The samples
obtained after the ﬁrst 5 min were expressed as the means ± S.E. of 26
diﬀerent preparations. *P < 0.05 vs. control, +P < 0.05 vs. 20 mM
taurine.
Fig. 4. Eﬀects of taurine on p38 MAP kinase and ERK 1/2 in cultured
HOB cells. Immunoprecipitation of ERK1/2 of HOB cells with no
treatment, treated with taurine alone, or treated with taurine plus
PD98059. HOB cells were treated with 20 mM taurine for 24 h prior to
the addition of 10 lM PD98059, and then harvested for the determi-
nation of MAPK levels. This picture shows the typical changes in
total- and phosphorylated-ERK 1/2 after exposure to 20 mM taurine
(A). The blots were quantiﬁed by laser scanning densitometry. The
data are reported as means ± S.E. of four diﬀerent preparations (B).
*P < 0.01 vs. control.
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PD98059. Fig. 4 shows the typical changes in total- and phos-
phorylated-ERK 1/2 following exposure to 20 mM taurine in
HOB cells. Using densitometry, the % variations of the taurine
treated groups (n = 4) compared with the non-treated groups
(100%) were 548.3 ± 39.6 (total-ERK 1/2), 426.0 ± 33.4 (phos-
phorylated-ERK 1/2), 100.7 ± 0.1 (total-p38 MAP kinase),
170.0 ± 7.7 (phosphorylated-p38 MAP kinase). Taurine in-
duced a signiﬁcant activation of ERK1/2. Pretreatment with
PD98059 inhibited the levels of taurine-stimulated ERK1/2
phosphorylation.4. Discussion
Taurine, 2-aminoethanesulfonic acid, is known to be in-
volved in bone metabolism. As a result of this study, taurine
was determined to induce cell proliferation in human osteo-
blast (HOB) cells. Recently, Yuan et al. [7] reported that the
taurine transporter is expressed within osteoblasts, which per-
form an important function in the maintenance of a high tau-
rine concentration in tissues, and taurine also promotes
osteoblast diﬀerentiation. Also, the results of their previous
study showed that taurine, an abundant free amino acid which
is present in bone tissue, increases the secretion of CTGF in adose- and time-dependent manner in the MC3T3-E1 murine
osteoblast line, and that this eﬀect is mediated by the ERK
pathway. These ﬁndings further show that osteoblasts can
function as a direct target of taurine [8]. Interestingly, taurine
augmented cell proliferation in HOB cells at 10 and 20 mM of
taurine treatment (Fig. 1). We determined that increased cell
viability in HOB cells as the result of taurine treatment is re-
lated to increments in Mg2+. Taurine treatment caused an in-
crease in total and intracellular magnesium concentrations in
HOB cells. In the previous study, it was suggested that the
modiﬁcation of biomaterials with a divalent cation (Mg2+) in-
duces an increase in the adhesion of osteoblasts to the altered
substrata via an integrin-mediated mechanism [18]. In the last
analysis, the augmentation of magnesium levels as the result of
taurine treatment contributes to an increase in the viability of
HOB cells.
Taurine generated a dose-dependent increase in [Mg2+]i. We
attempted to characterize the speciﬁc mechanisms of taurine-
induced [Mg2+]i increment in HOB cells. Although the mecha-
nisms underlying Mg2+ transport have yet to be isolated or
puriﬁed, experimental evidence supports the notion that the
intrusion of Mg2+ occurs via two distinct routes: an Na+-
dependent pathway and an Na+-independent pathway [19].
In the majority of cases, the intrusion of Mg2+ across the cell
membrane occurs via an Na+-dependent mechanism [20–23].
Although not structurally deﬁned, experimental data indicate
that this transporter is a Na+/ Mg2+ exchanger [24], with a stoi-
chiometry that varies from 1Na+ for 1Mg2+ to 3Na+ for
1Mg2+, according to the cell type or the experimental condi-
tions evaluated [24–26]. On the other hand, the presence of a
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a variety of mammalian cells [27–30]. This transporter is com-
monly inhibited by both lidocaine and imipramine. Our results
indicate that the Na+-dependent increase in [Mg2+]i as the re-
sult of taurine treatment is inhibited by lidocaine or imipra-
mine in HOB cells. Therefore, we suggest that the Na+-
dependent Mg2+ inﬂux pathway exploited by taurine in HOB
cells is a novel pathway, which is sensitive to lidocaine and
imipramine (Fig. 3B). The Na+-independent pathway appears
to extrude Mg2+ in exchange for extracellular Ca2+ [21,22] or
Mn2+ [31,32], or in cotransport with anions [33]. However,
the modality of the activation of this pathway remains largely
uncharacterized. In isolated porcine thick ascending limb cells,
Dai and Quamme [34] previously reported that Mg2+ transport
was inhibited by Ca2+ channel blockers, although it was also
inhibited by nitrendipine, which indicates that the Mg2+ inﬂux
pathway is a channel evidencing close homology with known
Ca2+ channels. In particular, nifedipine and its associated
dihydropyridines are clearly relevant to Mg2+ eﬄux channels.
Thus, the taurine-induced augmentation of [Mg2+]i in HOB
cells was inhibited by nifedipine (Fig. 3B).
The MAP kinase cascade is an important signaling system
by which cells can transducer extracellular stimuli into intra-
cellular responses [35,36]. An important observation presented
herein is that a speciﬁc ERK 1/2 antagonist (PD98059) [37] can
attenuate signiﬁcantly the taurine-induced increase in the
[Mg2+]i levels of cultured HOB cells, which suggests that
ERK 1/2 activation in the HOB cell performs a function in
the taurine-induced increase in the levels of [Mg2+]i. Recently,
Yuan et al. reported that taurine stimulates the expression of
CTGF in osteoblasts through the activation of the ERK signal
pathway. Also, Park et al. reported that taurine rapidly acti-
vated ERK2, and its activation occurred even at a concentra-
tion of 0.01 mM, which suggests that osteoblasts are extremely
sensitive to taurine [6]. After all, taurine-induced osteoblast
proliferation depends on the activation of ERK 1/2. On the
other hand, we may have mentioned previously that taurine in-
duced an increase in the total and intracellular magnesium
concentrations in the HOB cells. The increment of intracellular
magnesium as the result of taurine treatment contributes to an
increase in the proliferation of HOB cells. Recently, Kim et al.
[17] reported that the augmentation of intracellular magnesium
([Mg2+]i) in H9C2 cells may be related to the activation of the
ERK signal pathway. Therefore, taurine may exert an osteo-
blast proliferation eﬀect directly, by increasing the levels of
[Mg2+]i and/or via ERK1/2 activation.
Taken together, these results appear to indicate that taurine
operates directly on cultured HOB cells; it generates cell prolif-
eration, in part, via an increase in [Mg2+]I, accompanied by
ERK 1/2 activation.
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